Email
RSS20/11/08 - 21:45 ... source : UCLA
... on services By Gwen Driscoll | 11/20/2008 Senior citizens in California's Central Valley region have the worst health in the state and may provide a snapshot of the challenges California faces over the next two ...
20/11/08 - 21:13 ... source : University of Ottawa
... Awards ceremony being held this evening in Ottawa, Dr. Peter Tugwell, Professor in the Departments of Medicine and Epidemiology and Community Medicine at the Institute of Population Health, will be named Canada's 2008 Health Researcher ...
20/11/08 - 19:34 ... source : Atos Worldline
... November 2008 - Atos Worldline, an Atos Origin Company, has signed a 5-year contract with leading German health Insurance Company, Gmünder ErsatzKasse (GEK), to implement and operate the issuing and management of the new German ...
20/11/08 - 18:56 ... source : MHRA
20/11/08 - 17:56 ... source : University Hospitals
... leaders will gather at Rainbow Babies & Children's Hospital on Nov. 20 to join other children's hospitals across the nation in hosting simultaneous town hall meetings to discuss health care reform and the issues of ...
20/11/08 - 17:39 ... source : Roche
... today announced that the SATURN (SequentiAl Tarceva in UnResectable NSCLC) study met its primary endpoint of progression free survival. The study showed that Tarceva (erlotinib), when given in first line maintenance - immediately following initial ...
20/11/08 - 17:20 ... source : Watson Pharmaceuticals
... WPI), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for a 6-month formulation of TRELSTAR(R) (triptorelin pamoate), a luteinizing hormone releasing hormone (LHRH) agonist, has been accepted for filing by ...
20/11/08 - 16:49 ... source : Johnson & Johnson
20/11/08 - 12:44 ... source : GlaxoSmithKline
... the Netherlands Vaccine Institute (NVI) as the cervical cancer vaccine for the Dutch National Immunisation Programme (NIP). Issued: Thursday 20th November 2008, London UK GlaxoSmithKline's (GSK) cervical cancer vaccine, Cervarix TM, was today confirmed by ...
19/11/08 - 13:34 ... source : AstraZeneca
... ZACTIMA (vandetanib) in combination with chemotherapy agents docetaxel (ZODIAC) and pemetrexed (ZEAL) and as monotherapy (ZEST) in non-small cell lung cancer (NSCLC). Results from the ZODIAC and ZEAL studies showed advantages for vandetanib in combination ...
